Fig. 2.

Summary of studies evaluating the association between adjuvant radiotherapy and oncologic and survival outcomes in patients with adverse features after prostatectomy. (A) Overall survival. (B) Metastasis-free survival. (C) Biochemical progression-free survival. (D) Loco-regional recurrence-free survival. Note that ARO-96-02 reported on metastasis-free and overall survival but a hazard ratio was not reported and, therefore, this trial could not contribute to the meta-analysis of these outcomes. CI: confidence interval; IV: inverse variance; RT: radiation therapy.